BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28461492)

  • 1. SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors.
    Taracanova A; Alevizos M; Karagkouni A; Weng Z; Norwitz E; Conti P; Leeman SE; Theoharides TC
    Proc Natl Acad Sci U S A; 2017 May; 114(20):E4002-E4009. PubMed ID: 28461492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin.
    Taracanova A; Tsilioni I; Conti P; Norwitz ER; Leeman SE; Theoharides TC
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9381-E9390. PubMed ID: 30232261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondroitin sulfate inhibits secretion of TNF and CXCL8 from human mast cells stimulated by IL-33.
    Gross AR; Theoharides TC
    Biofactors; 2019 Jan; 45(1):49-61. PubMed ID: 30521103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E.
    Petra AI; Tsilioni I; Taracanova A; Katsarou-Katsari A; Theoharides TC
    Allergy Asthma Proc; 2018 Mar; 39(2):153-160. PubMed ID: 29490771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance P selectively activates TNF-alpha gene expression in murine mast cells.
    Ansel JC; Brown JR; Payan DG; Brown MA
    J Immunol; 1993 May; 150(10):4478-85. PubMed ID: 7683320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin.
    Theoharides TC; Zhang B; Kempuraj D; Tagen M; Vasiadi M; Angelidou A; Alysandratos KD; Kalogeromitros D; Asadi S; Stavrianeas N; Peterson E; Leeman S; Conti P
    Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4448-53. PubMed ID: 20160089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methoxyluteolin Inhibits Neuropeptide-stimulated Proinflammatory Mediator Release via mTOR Activation from Human Mast Cells.
    Patel AB; Theoharides TC
    J Pharmacol Exp Ther; 2017 Jun; 361(3):462-471. PubMed ID: 28404689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells.
    Asadi S; Alysandratos KD; Angelidou A; Miniati A; Sismanopoulos N; Vasiadi M; Zhang B; Kalogeromitros D; Theoharides TC
    J Invest Dermatol; 2012 Feb; 132(2):324-9. PubMed ID: 22089831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azelastine inhibits secretion of IL-6, TNF-alpha and IL-8 as well as NF-kappaB activation and intracellular calcium ion levels in normal human mast cells.
    Kempuraj D; Huang M; Kandere-Grzybowska K; Basu S; Boucher W; Letourneau R; Athanassiou A; Theoharides TC
    Int Arch Allergy Immunol; 2003 Nov; 132(3):231-9. PubMed ID: 14646384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clock-dependent temporal regulation of IL-33/ST2-mediated mast cell response.
    Kawauchi T; Ishimaru K; Nakamura Y; Nakano N; Hara M; Ogawa H; Okumura K; Shibata S; Nakao A
    Allergol Int; 2017 Jul; 66(3):472-478. PubMed ID: 28259547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells.
    Azzolina A; Bongiovanni A; Lampiasi N
    Biochim Biophys Acta; 2003 Dec; 1643(1-3):75-83. PubMed ID: 14654230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-33 stimulates human mast cell release of CCL5 and CCL2 via MAPK and NF-κB, inhibited by methoxyluteolin.
    Bawazeer MA; Theoharides TC
    Eur J Pharmacol; 2019 Dec; 865():172760. PubMed ID: 31669588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes.
    Guo CJ; Douglas SD; Gao Z; Wolf BA; Grinspan J; Lai JP; Riedel E; Ho WZ
    Glia; 2004 Nov; 48(3):259-66. PubMed ID: 15390113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells.
    Weng Z; Patel AB; Panagiotidou S; Theoharides TC
    J Allergy Clin Immunol; 2015 Apr; 135(4):1044-1052.e5. PubMed ID: 25498791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance P enhances the secretion of tumor necrosis factor-alpha from neuroglial cells stimulated with lipopolysaccharide.
    Luber-Narod J; Kage R; Leeman SE
    J Immunol; 1994 Jan; 152(2):819-24. PubMed ID: 7506735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves Rho family small GTPases.
    Zhao D; Kuhnt-Moore S; Zeng H; Pan A; Wu JS; Simeonidis S; Moyer MP; Pothoulakis C
    Biochem J; 2002 Dec; 368(Pt 2):665-72. PubMed ID: 12169092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of substance P receptors on cultured human spinal cord astrocytes: synergism of substance P with cytokines in inducing interleukin-6 and prostaglandin E2 production.
    Palma C; Minghetti L; Astolfi M; Ambrosini E; Silberstein FC; Manzini S; Levi G; Aloisi F
    Glia; 1997 Oct; 21(2):183-93. PubMed ID: 9336233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human skin mast cells produce TNF-alpha by substance P.
    Okayama Y; Ono Y; Nakazawa T; Church MK; Mori M
    Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():48-51. PubMed ID: 9758897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells.
    Moulin D; Donzé O; Talabot-Ayer D; Mézin F; Palmer G; Gabay C
    Cytokine; 2007 Dec; 40(3):216-25. PubMed ID: 18023358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytes.
    Karagiannides I; Kokkotou E; Tansky M; Tchkonia T; Giorgadze N; O'Brien M; Leeman SE; Kirkland JL; Pothoulakis C
    Proc Natl Acad Sci U S A; 2006 Mar; 103(13):5207-12. PubMed ID: 16549770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.